1.05
전일 마감가:
$1.04
열려 있는:
$1.04
하루 거래량:
57,753
Relative Volume:
0.59
시가총액:
$62.20M
수익:
-
순이익/손실:
$-25.65M
주가수익비율:
-2.1429
EPS:
-0.49
순현금흐름:
$-24.59M
1주 성능:
-4.55%
1개월 성능:
-7.89%
6개월 성능:
-16.00%
1년 성능:
-45.60%
Vivani Medical Inc Stock (VANI) Company Profile
명칭
Vivani Medical Inc
전화
818-833-5000
주소
1350 S. LOOP ROAD, ALAMEDA
VANI을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
VANI
Vivani Medical Inc
|
1.05 | 62.20M | 0 | -25.65M | -24.59M | -0.49 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
488.34 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
718.16 | 78.51B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
580.43 | 35.27B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
238.74 | 30.91B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.71 | 26.37B | 3.32B | -860.46M | -1.04B | -8.32 |
Vivani Medical Inc 주식(VANI)의 최신 뉴스
Lessons Learned From Vivani Medical's Study Of GLP-1 Implant - Clinical Leader
Vivani Medical’s chief business officer buys $1,110 in stock By Investing.com - Investing.com Australia
Vivani Medical’s chief business officer buys $1,110 in stock - Investing.com India
Second Sight Medical stock hits 52-week low at $1.1 amid challenges - Investing.com
Head to Head Review: Vivani Medical (NASDAQ:VANI) & BioLife Solutions (NASDAQ:BLFS) - Defense World
Comparing Precision Optics (NASDAQ:POCI) & Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update - MarketBeat
Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now - GlobeNewswire Inc.
Geode Capital Management LLC Purchases 15,008 Shares of Vivani Medical, Inc. (NASDAQ:VANI) - Defense World
Reviewing CONMED (NYSE:CNMD) and Vivani Medical (NASDAQ:VANI) - Defense World
SABBY MANAGEMENT, LLC Acquires Additional Shares in Bluejay Diag - GuruFocus.com
Financial Contrast: Getinge AB (publ) (OTCMKTS:GNGBY) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani begins exenatide implant trial for obesity in Australia - Yahoo Finance
EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia - AOL
Vivani Medical begins first human trial of implantable drug - Investing.com
Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia - Business Wire
Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Business Wire
Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Drops By 29.6% - MarketBeat
Financial Review: Vivani Medical (NASDAQ:VANI) vs. Heyu Biological Technology (OTCMKTS:HYBT) - Defense World
Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares - Simply Wall St
Vivani Medical: Q3 Earnings Snapshot - Darien Times
Vivani Medical Reports Q3 Loss, Advances GLP-1 Trials - TipRanks
Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Purchases 3,968,253 Shares - MarketBeat
Vivani medical director Gregg Williams buys $5 million in stock By Investing.com - Investing.com Nigeria
Vivani medical director Gregg Williams buys $5 million in stock - Investing.com India
Vivani Medical Secures Funding for GLP-1 Implant Trial - TipRanks
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results - Business Wire
Vivani Medical (NASDAQ:VANI) Now Covered by HC Wainwright - Defense World
HC Wainwright & Co. Initiates Coverage of Vivani Medical (VANI) with Buy Recommendation - MSN
3 US Penny Stocks To Monitor In October 2024 - Simply Wall St
Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024 - Business Wire
Vivani Medical's Market Cap Up US$6.6m Following Year Of Insider Stock Buying - Simply Wall St
Vivani Medical (NASDAQ:VANI) Shares Up 0.9%Here's Why - MarketBeat
Vivani Medical's chief business officer buys shares worth $2,835 - Investing.com India
Vivani Medical's chief business officer buys shares worth $2,835 By Investing.com - Investing.com Australia
Thursday's Insider Trading Moves: Top Buys and Sells in US Stocks - Investing.com India
Precision Optics (OTCMKTS:PEYE) & Vivani Medical (NASDAQ:VANI) Head-To-Head Analysis - Defense World
Vivani Medical (NASDAQ:VANI) Stock Quotes, Forecast and News Summary - Benzinga
Vivani Medical obtains Australian approval to begin GLP-1 implant trial - Yahoo Finance
Vivani Medical's implant trial gets Australian regulatory nod - Investing.com Australia
Vivani Medical's implant trial gets Australian regulatory nod By Investing.com - Investing.com Canada
Vivani Medical to Test Implant in Obese and Overweight Patients - Yahoo Finance
Vivani Medical Inc (VANI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):